LGC acquires antigens and antibodies company NAC
July 10, 2020 -- Life sciences company LGC has acquired the Native Antigen Company (NAC), an Oxford, U.K.-based supplier of infectious disease antigens and antibodies.
Zymeworks, Merck to develop multispecific antibodies
July 9, 2020 -- Merck has signed a research and licensing agreement to develop multispecific antibody therapeutic candidates using platforms from clinical-stage biopharmaceutical company Zymeworks.
Takeda, Twist partner on biologics discovery
July 9, 2020 -- Twist Bioscience and Takeda Pharmaceutical have formed a partnership for access to Twist's proprietary phage display libraries for the discovery of antibodies in Takeda's biologics pipeline.
Pfizer pledges $100M for antimicrobial resistance
July 9, 2020 -- Pfizer has pledged $100 million to the Antimicrobial Resistance Action Fund to address the need for new antibiotics due to the rapid rise of antibiotic-resistant infections.
$1.6B awarded to Novavax for COVID-19 vaccine
July 9, 2020 -- Novavax was awarded $1.6 billion by the U.S. government through Operation Warp Speed to deliver 100 million doses of a COVID-19 vaccine in 2021.
Xencor, Atreca to work on T cell-based cancer therapies
July 8, 2020 -- Biopharmaceutical company Xencor and biotechnology company Atreca have entered into a license agreement to research, develop, and commercialize T cell-engaging bispecific antibodies as potential cancer therapies.
CEPI expands Clover partnership on COVID-19 vaccine
July 8, 2020 -- The Coalition for Epidemic Prepardeness Innovations (CEPI) has expanded its partnership with Clover Biopharmaceuticals for the development and manufacture of Clover's COVID-19 S-Trimer vaccine candidate.
BD to provide injection devices for mass doses of COVID-19 vaccines
July 8, 2020 -- Becton Dickinson (BD) formed a strategic partnership with the Biomedical Advanced Research and Development Authority to develop new manufacturing lines for injection devices that will provide the U.S. government with hundreds of millions of syringes and needles to support pandemic vaccination efforts.
Cancer Research UK, Abcam partner on cancer antibodies
July 8, 2020 -- Abcam will create protein-based reagents for targets identified by Cancer UK-funded researchers. Antibodies that result from the partnership will be used to further understand cancer biology, create new diagnostic tools, and potentially develop novel therapies.
Pershing Square Foundation funds SARS-CoV-2 research
July 8, 2020 -- The Pershing Square Foundation has awarded $3 million to 19 researchers investigating the novel coronavirus.
Conferences
BioProcess International Europe
July 13-17
Central European Time Zone (CET) Netherlands
2020 ACCP Annual Meeting
September 20-22
Bethesda, Maryland United States
Bioprocess International West
September 21-24
Eastern Standard Time Zone (EST) United States
General Discussion
Topic Replies / Views Last Update
https://academic.oup.com/ve/pages/coronavirus-evolution
by Michael
0 / 47 More than 3 days ago
by Michael
PopSci Hails Impossible Burger 2.0 as Most Important Engineering Innovation in 2019
by Mahesh Gupta
0 / 14 More than 3 days ago
by Mahesh Gupta
Engineered Bacteria Produces BeeFree Honey
by Mahesh Gupta
0 / 12 More than 3 days ago
by Mahesh Gupta
Consumers' Preference to Buy Unlabeled Produce Increases after Exposure to GMO-labeled Pro
by Mahesh Gupta
0 / 15 More than 3 days ago
by Mahesh Gupta
Super-precise new CRISPR tool could tackle a plethora of genetic diseases
by Mahesh Gupta
0 / 14 More than 3 days ago
by Mahesh Gupta
To see more posts from our community or to share a post of your own, go to our community's forum page.
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter